[go: up one dir, main page]

EP0705426A4 - Titrages en une etape specifiques d'un antigene - Google Patents

Titrages en une etape specifiques d'un antigene

Info

Publication number
EP0705426A4
EP0705426A4 EP94920037A EP94920037A EP0705426A4 EP 0705426 A4 EP0705426 A4 EP 0705426A4 EP 94920037 A EP94920037 A EP 94920037A EP 94920037 A EP94920037 A EP 94920037A EP 0705426 A4 EP0705426 A4 EP 0705426A4
Authority
EP
European Patent Office
Prior art keywords
antigen
specific
step assays
assays
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP94920037A
Other languages
German (de)
English (en)
Other versions
EP0705426A1 (fr
Inventor
Steven Paul Miller
Nol Quiwa
Allan D Pronovost
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Quidel Corp
Original Assignee
Quidel Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Quidel Corp filed Critical Quidel Corp
Publication of EP0705426A1 publication Critical patent/EP0705426A1/fr
Publication of EP0705426A4 publication Critical patent/EP0705426A4/fr
Withdrawn legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54366—Apparatus specially adapted for solid-phase testing
    • G01N33/54386—Analytical elements
    • G01N33/54387—Immunochromatographic test strips
    • G01N33/54388—Immunochromatographic test strips based on lateral flow
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54366—Apparatus specially adapted for solid-phase testing
    • G01N33/54386—Analytical elements
    • G01N33/54387—Immunochromatographic test strips
    • G01N33/54388—Immunochromatographic test strips based on lateral flow
    • G01N33/54389—Immunochromatographic test strips based on lateral flow with bidirectional or multidirectional lateral flow, e.g. wherein the sample flows from a single, common sample application point into multiple strips, lanes or zones
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6854—Immunoglobulins
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/80—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood groups or blood types or red blood cells

Landscapes

  • Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
EP94920037A 1993-06-09 1994-05-24 Titrages en une etape specifiques d'un antigene Withdrawn EP0705426A4 (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US7508593A 1993-06-09 1993-06-09
US75085 1993-06-09
PCT/US1994/005870 WO1994029696A1 (fr) 1993-06-09 1994-05-24 Titrages en une etape specifiques d'un antigene

Publications (2)

Publication Number Publication Date
EP0705426A1 EP0705426A1 (fr) 1996-04-10
EP0705426A4 true EP0705426A4 (fr) 1998-07-08

Family

ID=22123450

Family Applications (1)

Application Number Title Priority Date Filing Date
EP94920037A Withdrawn EP0705426A4 (fr) 1993-06-09 1994-05-24 Titrages en une etape specifiques d'un antigene

Country Status (3)

Country Link
EP (1) EP0705426A4 (fr)
JP (1) JPH08511621A (fr)
WO (1) WO1994029696A1 (fr)

Families Citing this family (47)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5415994A (en) * 1993-08-02 1995-05-16 Quidel Corporation Lateral flow medical diagnostic assay device with sample extraction means
US5773234A (en) * 1995-08-07 1998-06-30 Quidel Corporation Method and device for chlamydia detection
GB9601404D0 (en) * 1996-01-24 1996-03-27 Indoor Biotechnologies Ltd Allergen assay
US5753517A (en) * 1996-03-29 1998-05-19 University Of British Columbia Quantitative immunochromatographic assays
US6391569B1 (en) 1996-09-18 2002-05-21 Heska Corporation Method to detect Dirofilaria immitis infection
DE69732131T2 (de) 1996-10-25 2005-12-15 Idexx Laboratories, Inc. Immuno-Assay-Vorrichtung mit teilbarem Gehäuse
US6060326A (en) * 1997-04-07 2000-05-09 Heska Corporation Method to detect canine IgE and kit therefor
DE19721151C2 (de) * 1997-05-21 2002-10-31 Merck Patent Gmbh Streifentest zur in-vitro-Allergiediagnostik
SE9704935D0 (sv) * 1997-12-30 1997-12-30 Pharmacia & Upjohn Diag Ab Analysmetod med partiklar
WO1999040438A1 (fr) * 1998-02-03 1999-08-12 Synbiotics Corporation Dispositifs et procedes de mesure des titres d'anticorps immunoprotecteurs
EP1064553A4 (fr) * 1998-03-16 2001-09-12 Quidel Corp Dispositif et procede pour dosage immunologique
DE69939260D1 (de) * 1998-06-24 2008-09-18 Alk Abello As Verfahren zum nachweis von antikörpern in flüssigen proben
EP0973034A1 (fr) * 1998-07-16 2000-01-19 Microbe Scope AG Immunoessais et dispositifs pour leur fonctionnement
US6824997B1 (en) * 1998-09-18 2004-11-30 Binax, Inc. Process and materials for the rapid detection of streptococcus pneumoniae employing purified antigen-specific antibodies
US7759133B2 (en) 1998-12-22 2010-07-20 Alk-Abello A/S Method of detecting and/or quantifying a specific IgE antibody in a liquid sample
WO2001029078A2 (fr) 1999-10-15 2001-04-26 Heska Corporation Procede de production et d'utilisation de proteines de groupe 1 d'acarien
TWI286159B (en) * 2000-07-07 2007-09-01 Diagnostics For The Real World Improved stability of hybridisation interactions in dipstick assays
GB0016836D0 (en) 2000-07-07 2000-08-30 Lee Helen Improved dipstick assays (1)
GB0016814D0 (en) 2000-07-07 2000-08-30 Lee Helen Improved dipstick assays (3)
GB0025245D0 (en) * 2000-10-14 2000-11-29 Lee Helen Multiple target detection
GB0031391D0 (en) * 2000-12-21 2001-02-07 Lee Helen Pre-donation testing
JP2004521336A (ja) * 2001-01-03 2004-07-15 ヘスカ コーポレイション アレルゲン特異的ＩｇＥの検出
US6818181B2 (en) 2001-03-15 2004-11-16 Savyon Diagnostics Ltd. Kit and method for detecting food allergies
JP4578709B2 (ja) * 2001-03-28 2010-11-10 三菱化学メディエンス株式会社 複数項目同時分析可能なイムノクロマトグラフ法及びイムノクロマトグラフ用ストリップ
DK1384075T3 (da) 2001-03-28 2010-04-26 Heska Corp Fremgangsmåder til detektering af tidlig renal sygdom hos dyr
EP1387170B1 (fr) 2001-04-12 2012-03-21 ARKRAY, Inc. Instrument d'analyse de prelevement
EP1253203A1 (fr) * 2001-04-25 2002-10-30 Becton Dickinson and Company Germination, développement, immobilisation et détéction rapide des microorganismes
JP4627607B2 (ja) * 2001-05-14 2011-02-09 三菱化学メディエンス株式会社 複数項目及び総含有量の同時分析可能なイムノクロマトグラフ法及びイムノクロマトグラフ用ストリップ
GB0128310D0 (en) * 2001-11-27 2002-01-16 York Lab Ltd Test
AU2003261444A1 (en) * 2002-08-09 2004-02-25 Martin H. Bluth A method for monitoring the effectiveness of tetracycline in the treatment of asthma
WO2004084841A2 (fr) 2003-03-27 2004-10-07 Heska Corporation Nouveaux anticorps d'albumine anti-feline et procedes de detection de maladies renales precoces
DE10330981B4 (de) * 2003-07-09 2010-04-01 Medion Diagnostics Ag Vorrichtung und Verfahren zur simultanen Durchführung von Blutgruppenbestimmung, Serumgegenprobe und Antikörpersuch-Test
DE10330982A1 (de) 2003-07-09 2005-02-17 Prisma Diagnostika Gmbh Vorrichtung und Verfahren zur simultanen Bestimmung von Blutgruppenantigenen
JPWO2005015217A1 (ja) * 2003-08-11 2006-10-05 協和メデックス株式会社 測定対象物測定器具、測定装置および測定方法
US7241417B2 (en) 2004-07-29 2007-07-10 Savyon Diagnostics Ltd. Assay device
JP4621583B2 (ja) * 2005-12-09 2011-01-26 シャープ株式会社 タンパク質検査体、及びその製造方法、並びにタンパク質検査体を用いたタンパク質検出装置
AU2009247267B2 (en) 2008-05-12 2014-11-06 Animal Allergy Clinical Laboratories Method for quantification of antigen-specific canine or human IgE
JP5813481B2 (ja) * 2011-11-29 2015-11-17 Kddi株式会社 バイオセンサおよび被験液の測定方法
US9678074B2 (en) 2012-03-28 2017-06-13 The United States Of America, As Represented By The Secretary, Dept. Of Health And Human Services Interferon-λ4 (IFNL4) protein, related nucleic acid molecules, and uses thereof
US10363288B2 (en) 2015-01-14 2019-07-30 National Jewish Health Insulin mimotopes and methods of using the same
EP3432877B1 (fr) 2016-03-24 2023-01-11 ImmunoMolecular Therapeutics, Inc. D-alpha-méthyldopa pour le traitement de maladie auto-immune
US11052060B2 (en) 2018-02-12 2021-07-06 The Regents Of The University Of Colorado, A Body Corporate Compounds and methods for treating autoimmunity
WO2019166544A1 (fr) * 2018-02-28 2019-09-06 Asit Biotech Sa Détection d'anticorps bloquants
US11013707B2 (en) 2018-03-23 2021-05-25 The Regents Of The University Of Colorado, A Body Corporate Administration of oral methyldopa
JP2022505934A (ja) * 2018-10-24 2022-01-14 オラシュアテクノロジーズ， インコーポレイテッド 差異的アイソタイプ検出のためのラテラルフローアッセイ
JP7535104B2 (ja) * 2019-10-27 2024-08-15 チャン，ケ ＩｇＥのリバースＬＦＩＡ
EP4200288A4 (fr) 2020-08-21 2024-10-30 ImmunoMolecular Therapeutics, Inc. Composés et méthodes de traitement de troubles auto-immuns par ciblage de hla-dq2

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4273756A (en) * 1978-07-28 1981-06-16 Abbott Laboratories Immunoassay for class specific antibodies
US4256833A (en) * 1979-01-08 1981-03-17 Majid Ali Enzyme immunoassay for allergic disorders
US4459360A (en) * 1981-10-05 1984-07-10 Mast Medical Industries, Ltd. Multiple-component binding assay system and method of making and using it
SU1165365A1 (ru) * 1983-01-11 1985-07-07 Горьковский Научно-Исследовательский Педиатрический Институт Способ дифференциальной диагностики пищевой аллергии
US4703017C1 (en) * 1984-02-14 2001-12-04 Becton Dickinson Co Solid phase assay with visual readout
IL75464A (en) * 1984-06-12 1990-08-31 Orgenics Ltd Method and apparatus for multi-analyte assay
DE3445816C1 (de) * 1984-12-15 1986-06-12 Behringwerke Ag, 3550 Marburg Flaechenfoermiges diagnostisches Mittel
US5079142A (en) * 1987-01-23 1992-01-07 Synbiotics Corporation Orthogonal flow immunoassays and devices
US4920046A (en) * 1987-02-20 1990-04-24 Becton, Dickinson And Company Process, test device, and test kit for a rapid assay having a visible readout
DE291194T1 (de) * 1987-04-27 1992-03-19 Unilever N.V., Rotterdam Immunoassays und vorrichtungen dafuer.
US4943522A (en) * 1987-06-01 1990-07-24 Quidel Lateral flow, non-bibulous membrane assay protocols
US5091318A (en) * 1990-04-13 1992-02-25 Abbott Laboratories Binding of allergens to a solid phase
EP0582672A4 (en) * 1991-04-26 1994-06-29 Emanuel Calenoff Methods to detect and treat diseases caused by bacterial allergens

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
No further relevant documents disclosed *

Also Published As

Publication number Publication date
EP0705426A1 (fr) 1996-04-10
JPH08511621A (ja) 1996-12-03
WO1994029696A1 (fr) 1994-12-22

Similar Documents

Publication Publication Date Title
EP0705426A4 (fr) Titrages en une etape specifiques d'un antigene
GB2269440B (en) Double-mass flywheel
GB9412166D0 (en) Retargetting antibodies
IL100841A0 (en) Immunoassay
AU127304S (en) Case
ZA96841B (en) Structural member
SG63596A1 (en) Receptor function assays
ZA946158B (en) Methyl 3-methoxy-2-phenyl-acrylates
EP0869176A4 (fr) Autoantigenes
GB9107983D0 (en) Assays
GB2282622B (en) Cover member
GB9318105D0 (en) Receptor action
GB2279681B (en) Reflective studs
GB9506850D0 (en) Fastening means
GB9222021D0 (en) Assay
GB9312638D0 (en) Assay
GB9308544D0 (en) Assay
GB9320508D0 (en) Antibodies
GB9309884D0 (en) Antibodies
HU9200962D0 (en) Flywheel
GB9424925D0 (en) Immunoassay
GB9312415D0 (en) Altered antibodies
HU9500284V0 (en) Case
GB9501622D0 (en) Immunoassay
GB9501416D0 (en) Immunoassay

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 19951218

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): DE FR GB IT

A4 Supplementary search report drawn up and despatched

Effective date: 19980522

AK Designated contracting states

Kind code of ref document: A4

Designated state(s): DE FR GB IT

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION HAS BEEN WITHDRAWN

18W Application withdrawn

Withdrawal date: 20010921